Barchart.com
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Menu
alerts false
Stocks | Futures | Watchlist | News | More
 
Advanced search
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Prothena Corp (PRTA)

Prothena Corp (PRTA)
9.20 x 4 10.00 x 2
Post-market by (Cboe BZX)
9.65 +0.06 (+0.63%) 04/24/25 [NASDAQ]
9.20 x 4 10.00 x 2
Post-market 9.68 +0.03 (+0.31%) 19:52 ET
News & Headlines for Thu, Apr 24th, 2025
Notes
Alerts
Watch
    Add or delete the symbol from one or more Watchlists.
  • Create New Watchlist
    This name already in use.
Help
Go To:
Prothena: Q4 Earnings Snapshot AP - Thu Feb 20, 3:22PM CST

Prothena: Q4 Earnings Snapshot

PRTA : 9.65 (+0.63%)
Roche's Prasinezumab Misses Goal in Parkinson's Disease Study
Roche's Prasinezumab Misses Goal in Parkinson's Disease Study Zacks Investment Research - Thu Dec 19, 2024

Roche RHHBY announced data from the phase IIb PADOVA study which evaluated its investigational monoclonal antibody, prasinezumab, for treating people with early-stage Parkinson’s disease.The double-blind...

CSTL : 20.93 (-1.60%)
PRTA : 9.65 (+0.63%)
RHHBY : 39.7500 (+1.56%)
SPRO : 0.7250 (-0.29%)
Prothena: Q3 Earnings Snapshot AP - Tue Nov 12, 2024

Prothena: Q3 Earnings Snapshot

PRTA : 9.65 (+0.63%)
Prothena: Q2 Earnings Snapshot AP - Thu Aug 8, 2024

Prothena: Q2 Earnings Snapshot

PRTA : 9.65 (+0.63%)
Prothena Reports First Quarter 2023 Financial Results and Business Highlights Business Wire - Thu May 4, 2023

Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, today reported financial...

PRTA : 9.65 (+0.63%)
Prothena to Report First Quarter 2023 Financial Results on May 4 Business Wire - Thu Apr 27, 2023

Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, today announced that...

PRTA : 9.65 (+0.63%)
Prothena to Participate in 2023 Bank of America Healthcare Conference Business Wire - Mon Apr 24, 2023

Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, today announced that...

PRTA : 9.65 (+0.63%)
Walgreens and Prothena Partner to Increase Access and Enrollment in Alzheimer’s Disease Clinical Trial Business Wire - Thu Apr 13, 2023

Walgreens and Prothena today announced a collaboration to accelerate patient identification and recruitment for Prothena’s ongoing ASCENT-2 multiple ascending dose clinical trial evaluating the safety...

WBA : 11.03 (+0.36%)
PRTA : 9.65 (+0.63%)
Prothena Presents New Preclinical Data Supporting Best-in-Class Profile of PRX012, a Next-Generation Anti-Amyloid Beta Antibody, at AD/PD 2023 Business Wire - Fri Mar 31, 2023

Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, today announced new...

PRTA : 9.65 (+0.63%)
Prothena to Participate in Stifel 2023 Virtual CNS Days Business Wire - Tue Mar 21, 2023

Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, today announced that...

PRTA : 9.65 (+0.63%)

Barchart Exclusives

1 ‘Strong Buy’ Dividend Stock to Buy for an ‘America First’ World Barchart - Thu Apr 24, 6:30PM CDT
GE Aerospace is emerging as a top “Strong Buy” dividend stock, with an 11% jump in revenue and a nearly $1 billion investment in U.S. manufacturing. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective
Wed, Apr 30, 2025 5:00 PM UTC
Reserve Your Spot